Zheng Xing Xing Ye Ri Bao·2025-09-04 08:50Market Overview - The chemical pharmaceutical sector experienced a decline of 2.93% on September 4, with Nanjing New Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Notable gainers in the chemical pharmaceutical sector included: - Haijing Pharmaceutical: closed at 21.20, up 9.67% with a trading volume of 55,600 shares [1] - Jiankai Technology: closed at 99.80, up 7.60% with a trading volume of 44,400 shares [1] - Fuyuan Pharmaceutical: closed at 27.13, up 6.98% with a trading volume of 384,900 shares [1] - Conversely, significant decliners included: - Nanjing New Pharmaceutical: closed at 13.27, down 10.82% with a trading volume of 240,800 shares [2] - Maiwei Biotech: closed at 54.22, down 9.59% with a trading volume of 278,800 shares [2] - Yipinhong: closed at 67.27, down 7.58% with a trading volume of 124,800 shares [2] Capital Flow - The chemical pharmaceutical sector saw a net outflow of 2.173 billion yuan from institutional investors, while retail investors contributed a net inflow of 1.619 billion yuan [2][3] - The capital flow for specific stocks indicated: - Fuyuan Pharmaceutical had a net inflow of 212 million yuan from institutional investors [3] - Chenshin Pharmaceutical experienced a net inflow of 117 million yuan from institutional investors [3] - Qianyan Biotech had a net inflow of 102 million yuan from institutional investors [3]